In her current role, in addition to the coordination and delivery of specialist training for pharmacy and medical health professionals, Michelle leads on the strategic workforce development of our advanced practice pharmacists across care settings, including increasing pharmacist engagement in portfolio work and research as part of their career pathway. She was a Diabetes Specialist Pharmacist/Senior Clinical Pharmacist at a primary care network, who previously worked for the CCG and delivered primary care diabetes cardiovascular risk clinics. The diabetes medicines optimisation service was provided to the General Practice to improve the three treatment targets and supported the completion of the nine care processes. Prior to these roles, she has been a hospital Diabetes & Endocrinology Specialist Pharmacist and Lecturer in Pharmacy Practice at The University of Bradford. She continues to be a Visiting Lecturer for diabetes medicines optimisation within the postgraduate clinical diploma programme at The Manchester School of Pharmacy. Michelle sits on the UKCPA Diabetes and Endocrinology Committee. She collaborates with accredited training providers to develop and deliver national and regional diabetes education to primary and secondary care health professionals. Michelle is on the Editorial Advisory Board of Clinical Pharmacist and contributes as a trainer and reviewer for the CPPE diabetes and endocrinology learning programmes. She writes and reviews diabetes-related publications in peer-reviewed journals. She updated the postgraduate Type 1 diabetes module for Medway School of Pharmacy and contributed to the second edition of Drugs in Use. She was a member of the NCEPOD study advisory group on the peri-operative management of people with diabetes. She is currently undertaking a PhD study exploring the barriers and enablers in supporting primary care healthcare professionals to improve type 2 diabetes self-management. The study will also aim to design a professional support tool for routine use in the primary care setting based on the qualitative findings from the first phase of the study.